Rein Therapeutics, Inc. (RNTX) SEC Filings — 2025
23 SEC filings for Rein Therapeutics, Inc. (RNTX) in 2025.
Filings
- Rein Therapeutics Terminates Material Agreement — 8-K · Dec 11, 2025
- Rein Therapeutics Faces FDA Clinical Hold, Cash Dwindles Amidst Losses — 10-Q · Nov 14, 2025
- Rein Therapeutics, Inc. 8-K Filing — 8-K · Nov 3, 2025
- Rein Therapeutics Enters Material Agreement, Discloses Financial Obligations — 8-K · Oct 24, 2025
- Rein Therapeutics Files 8-K — 8-K · Oct 9, 2025
- Rein Therapeutics Files 8-K — 8-K · Sep 22, 2025
- Rein Therapeutics Enters Material Agreement, Faces Financial Obligations — 8-K · Sep 9, 2025
- Rein Therapeutics Secures $15M Equity Line, Faces LTI-03 Clinical Hold — S-1 · Sep 3, 2025
- Rein Therapeutics Files 8-K — 8-K · Aug 19, 2025
- Rein Therapeutics Faces FDA Clinical Hold, Cash Dwindles Amidst Losses — 10-Q · Aug 14, 2025
- Rein Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · Jul 30, 2025
- Rein Therapeutics, Inc. Files 8-K — 8-K · Jul 23, 2025
- Rein Therapeutics Files 8-K — 8-K · Jul 11, 2025
- Rein Therapeutics to be Acquired by 03 Life Sciences — 8-K · Jun 24, 2025
- Rein Therapeutics to be Acquired by 03 Life Sciences — 8-K · Jun 12, 2025
- Rein Therapeutics Files 8-K on Operations and Financials — 8-K · May 15, 2025
- Rein Therapeutics Files Q1 2025 10-Q — 10-Q · May 15, 2025
- Rein Therapeutics Files DEF 14A, Formerly Aileron Therapeutics — DEF 14A · May 12, 2025
- Rein Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
- Rein Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · Apr 22, 2025
- Rein Therapeutics Changes Auditors Amidst Reporting Disagreement — 8-K · Apr 17, 2025
- Rein Therapeutics Files 2024 10-K, Cites Name Change & Financials — 10-K · Apr 7, 2025
- Rein Therapeutics Files 8-K with Corporate Updates — 8-K · Jan 10, 2025